03 March 2015 21 4K Report

The majority of experiments performing adoptive transfers of lymphocytes (T or B) into immunodeficient mice inject the cells into the recipient animal by intravenous (IV) means. This is usually performed either by tail vein or retro-orbitally. However, several reports have demonstrated very similar distribution and function of lymphocytes in recipient mice when comparing IV versus intraperitoneal (IP) routes of injection (examples: PMID - 9246787, 16699367). Moreover, anatomically cells injected IP should in theory enter the lymphatics through the peritineal cavity and into circulation thereafter, thus once again suggesting route of injection should be irrelevant. 

With IV injection techniques having a relatively high failure rate (dependent on operator of course) and the needs for restraint/anesthesia, why do so many labs continue to use IV injections for lymphocyte adoptive transfer instead of IP?  

Similar questions and discussions